Categories
Connect with us on LinkedIn
Do Patients Really Understand Clinical Trials?
Poor comprehension of informed consent disrupts trials. Here’s how to fix it—with data, tech, and actual patient understanding.
The Catch-22 of eConsent: The Missed Opportunity for Improved Clinical Trials
It’s time to move beyond digital PDFs. Discover how real eConsent can transform trials, reduce dropout, and respect...
Clinical Trials Aren’t Just About Patients (and That’s Okay)
This article explores the debate between patient-centricity and protocol-centricity in clinical trials, featuring insights from Derk Arts (Castor)...
A New Perspective on Clinical Research: Accessibility and Innovation
Joost Rigter’s inspiring journey highlights the importance of accessibility in clinical research. From AI-driven tools to simplified communication,...
Waiver of Consent vs Waiver of Written Consent
One is very common, the other is rarely granted. Learn the key differences between waiver of consent &...
10 FAQs on eConsent
To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address...
Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials
At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials
A Digital-First Mindset Shift on eConsent
eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical...
Preparing Your eConsent Study for IRB Approval
In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare...
Unlocking the power of Real-World Evidence in FDA submissions
An avalanche of data from so many real-world sources is available today, with the promise of more data...
5 steps for patient engagement and better outcomes in decentralized clinical trials
For successful decentralized clinical trials, researchers must encourage patient engagement. Learn 5 steps that modern companies are taking...
The future of rare disease research
Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may...
3 Ways eConsent Tackles the Challenges of Modern Clinical Trials
Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it's now a major part of clinical research....
The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very...
What Is eConsent in Clinical Trials?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future...
Three Ways Remote eConsent Improves Trial Efficiency
eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for...
Video Conferencing for Remote eConsent: 5 Reasons to Make the Switch
Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5...
How to Prepare an IRB Submission for a Remote eConsent Study
If you are planning on using eConsent in a trial, you’ll need to include it in your IRB...